Risk of late-onset depression and cognitive decline: Results from inflammatory proteome analyses in a prospective population-based cohort study
The American Journal of Geriatric Psychiatry Dec 08, 2021
Perna L, Trares K, Perneczky R, et al. - Using data from an ongoing population-based cohort study of older adults, researchers sought to determine if late-onset depression and cognitive decline due to vascular pathology (vascular dementia) share a common inflammatory etiology.
Researchers randomly selected a subgroup of participants of the ESTHER study (n = 1,665).
With the Olink Target 96, measurement of inflammatory biomarkers was done in baseline samples.
Analysis revealed the occurrence of changes in inflammatory markers years before clinical diagnosis of depression.
For risk of late-onset depression, the strongest inflammatory marker was interleukin 10 and the odds for late-onset depression and vascular dementia exhibited a similar monotonic rise with increasing levels of interleukin 10.
Risk stratification could be done using information relating to changes in inflammatory markers, especially interleukin 10, but the information did not allow differentiation of late-onset depression from vascular dementia in early stages.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries